The Role of Autophagy in Pancreatic Cancer-Recent Advances

Maria New1, Sharon Tooze1

  • 1Molecular Cell Biology of Autophagy Laboratory, The Francis Crick Institute, London NW1 1AT, UK.

Biology
|January 8, 2020
PubMed

Insights

Pancreatic cancer (PDAC) is deadly due to late diagnosis and drug resistance. Autophagy, a cell recycling process, is vital for PDAC survival and metabolism, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5-year survival rate of 9%.
  • Challenges in PDAC treatment include late diagnosis, drug resistance, and metastasis.
  • Understanding PDAC biology and identifying therapeutic targets are crucial.

Purpose of the Study:

  • To review recent advances in understanding the role and regulation of autophagy in PDAC.
  • To explore the dual role of autophagy in cancer, distinguishing its context-dependent functions.
  • To highlight autophagy's necessity for PDAC tumor survival and metabolism.

Main Methods:

  • Literature review of recent research on autophagy in PDAC.
  • Analysis of studies investigating the regulatory mechanisms of autophagy.
  • Synthesis of evidence on autophagy's impact on PDAC cell homeostasis and metabolism.

Main Results:

  • Autophagy plays a critical role in maintaining PDAC cell survival and metabolic processes.
  • Evidence suggests autophagy can be both tumor-suppressive and tumor-promoting, depending on the context.
  • Specific regulatory pathways of autophagy in PDAC are increasingly being elucidated.

Conclusions:

  • Autophagy is essential for PDAC progression and survival.
  • Targeting autophagy presents a promising therapeutic strategy for PDAC.
  • Further research into autophagy regulation is needed to optimize PDAC treatment.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K